Skip to content

Ardelyx ARDX EV / sales

EV / sales at other companies

Amgen logo
AmgenAMGN
6.6×+0.1×
Bausch Health Companies logo
Bausch Health CompaniesBHC
-0.3×
AbbVie logo
AbbVieABBV
7.5×+1.0×
XER
Xeris Biopharma Holdings, Inc.XERS
3.6×-1.1×
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
7.9×+0.4×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
4.3×-0.4×

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+79.5%
Enterprise value$1.71B+74.8%
P/S3.6×+1.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Calculated from Ardelyx’s reported figures.

Based on the most recent quarter.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's EV / sales?
Ardelyx (ARDX) reported EV / sales of 3.8× in Q1 2026.
How has Ardelyx's EV / sales changed year-over-year?
Ardelyx's EV / sales increased by 7.5% year-over-year, from 3.6× to 3.8×.
What is the long-term trend for Ardelyx's EV / sales?
Over 5 years (2020 to 2025), Ardelyx's EV / sales has grown at a -46.2% compound annual growth rate (CAGR), from 84.7× to 3.8×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.